Sanjiv Dhingra

Associate Professor and Director Canada Italy Tissue Engineering Program

University of Manitoba

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Tissue Engineering Tissue Engineering professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sanjiv Dhingra is an Associate Professor and Director of the Canada Italy Tissue Engineering Program at the University of Manitoba, Canada. His research focuses on stem cell therapy, myocardial regeneration, and the applications of MXenes in medical diagnostics and therapeutics. Recent publications include studies on generating new human induced pluripotent stem cell lines and exploring the mechanisms of cardiovascular conditions related to COVID-19 infection.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (1)

Ahmad Amiri

Assistant Professor

University of Colorado Boulder

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sanjiv Dhingra

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Generation of a new human iPSC cell line (UOMi010-A) from a patient with hypophosphatasia

Reprogramming of peripheral blood mononuclear cells from a patient with hypophosphatasia to generate iPSC line (UOMi011-A)

MXenes as emerging materials to repair electroactive tissues and organs

Periodic Table of Immunomodulatory Elements and Derived Two‐Dimensional Biomaterials

MXenes in healthcare: transformative applications and challenges in medical diagnostics and therapeutics

Human Antigen R, a Myofibroblast-Specific Target in Treating Cardiac Fibrosis

Stem cell therapy for cardiac regeneration: past, present, and future

Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy

An insight into the mechanisms of COVID-19, SARS-CoV2 infection severity concerning β-cell survival and cardiovascular conditions in diabetic patients

Conversion of 2D MXene to Multi‐Low‐Dimensional GerMXene Superlattice Heterostructure

Development of Fluorine‐Free Tantalum Carbide MXene Hybrid Structure as a Biocompatible Material for Supercapacitor Electrodes

Fabrication of Smart Tantalum Carbide MXene Quantum Dots with Intrinsic Immunomodulatory Properties for Treatment of Allograft Vasculopathy

Carbon nanomaterials for cardiovascular theranostics: Promises and challenges

Metformin impairs homing ability and efficacy of mesenchymal stem cells for cardiac repair in streptozotocin-induced diabetic cardiomyopathy in rats

Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome

Hypoxia-induced downregulation of cyclooxygenase 2 leads to the loss of immunoprivilege of allogeneic mesenchymal stem cells.

Induced pluripotent stem cell line UOMi002-A from a patient with Leigh syndrome with compound heterozygous mutations in the NDUFV1 gene.

Collaborators (1)

Ahmad Amiri

Make your next move.